Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Vitamin B6 metabolism determines T cell anti-tumor responses

ABSTRACT: Vitamin B6 metabolism determines T cell anti-tumor responses

PROVIDER: PRJNA758697 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR15663766_1.fastq.gz	Fastqsanger.gz
	SRR15663766_2.fastq.gz	Fastqsanger.gz
	SRR15663767_1.fastq.gz	Fastqsanger.gz
	SRR15663767_2.fastq.gz	Fastqsanger.gz
	SRR15663768_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Vitamin B6 metabolism determines T cell anti-tumor responses

Project description:Targeting T cell metabolism is an established method of immunomodulation. Following activation, T cells engage distinct metabolic programs leading to the uptake and processing of nutrients that determine cell proliferation and differentiation. Redirection of T cell fate by modulation of these metabolic programs has been shown to boost or suppress immune responses in vitro and in vivo. Using publicly available T cell transcriptomic and proteomic datasets we identified vitamin B6-dependent transaminases as key metabolic enzymes driving T cell activation and differentiation. Inhibition of vitamin B6 metabolism using the pyridoxal 5’-phosphate (PLP) inhibitor, aminoxyacetic acid (AOA), suppresses CD8+ T cell proliferation and effector differentiation in a dose-dependent manner. We show that pyridoxal phosphate phosphatase (PDXP), a negative regulator of intracellular vitamin B6 levels, is under the control of the hypoxia-inducible transcription factor (HIF1), a central driver of T cell metabolism. Furthermore, by adoptive transfer of CD8 T cells into a C57BL/6 mouse melanoma model, we demonstrate the requirement for vitamin B6-dependent enzyme activity in mediating effective anti-tumor responses. Our findings show that vitamin B6 metabolism is required for CD8+ T cell proliferation and effector differentiation in vitro and in vivo. Targeting vitamin B6 metabolism may therefore serve as an immunodulatory strategy to improve anti-tumor immunotherapy.

2021-08-31 | GSE182999 | GEO

Vitamin B6 Metabolism Determines T Cell Anti-Tumor Responses.

Project description:Targeting T cell metabolism is an established method of immunomodulation. Following activation, T cells engage distinct metabolic programs leading to the uptake and processing of nutrients that determine cell proliferation and differentiation. Redirection of T cell fate by modulation of these metabolic programs has been shown to boost or suppress immune responses in vitro and in vivo. Using publicly available T cell transcriptomic and proteomic datasets we identified vitamin B6-dependent transaminases as key metabolic enzymes driving T cell activation and differentiation. Inhibition of vitamin B6 metabolism using the pyridoxal 5'-phosphate (PLP) inhibitor, aminoxyacetic acid (AOA), suppresses CD8+ T cell proliferation and effector differentiation in a dose-dependent manner. We show that pyridoxal phosphate phosphatase (PDXP), a negative regulator of intracellular vitamin B6 levels, is under the control of the hypoxia-inducible transcription factor (HIF1), a central driver of T cell metabolism. Furthermore, by adoptive transfer of CD8 T cells into a C57BL/6 mouse melanoma model, we demonstrate the requirement for vitamin B6-dependent enzyme activity in mediating effective anti-tumor responses. Our findings show that vitamin B6 metabolism is required for CD8+ T cell proliferation and effector differentiation in vitro and in vivo. Targeting vitamin B6 metabolism may therefore serve as an immunodulatory strategy to improve anti-tumor immunotherapy.

| S-EPMC8891565 | biostudies-literature

Vitamin B6 reduces hippocampal apoptosis in experimental pneumococcal meningitis

Project description:Hippocampal apoptosis is a characteristic feature of penumococcal meningitis associated with learning and memory deficitis as a sequel of the disease. We investigated the effect of vitamin B6 using an established infant rat model of experimental pneumococcal meningitis by histomorphology, transcriptomics and measurement of cellular nicotine amide adenine dinucleotide content. The data provides evidence that vitamin B6 is neuroprotecitve in terms of reduced hippocampal apoptosis involving reduction of the inflammatory response, preservation of cellular energy stores and up-regulated brain-derived neurotrophic factor levels.

2012-02-20 | E-MEXP-3555 | biostudies-arrayexpress

Vitamin B6 addiction in acute myeloid leukemia

Project description:Vitamin B6 addiction in acute myeloid leukemia

| PRJNA587508 | ENA

Effect of dietary vitamin B6 on white adipose tissue

Project description:Transcriptional profiling of mouse white adipose tissues The objective of this study is to explore the relationship between vitamin B6 activity and chronic inflammation of white adipose tissue in mice fed a high-fat diet. Twenty-four CD-1 mice were divided into two groups (n = 12) and fed either a 1 mg pyridoxine (PN) HCl /kg diet or a 35 mg PN HCl /kg diet for 8 weeks. We isolated total RNA from epididymal white adipose tissue of each group and compared gene expression profiles by DNA microarray data analysis.

2013-01-12 | GSE43465 | GEO

Effect of dietary vitamin B6 on white adipose tissue

2013-01-12 | E-GEOD-43465 | biostudies-arrayexpress

Vitamin B6 Effects on one-carbon metabolism

Project description:Vitamin B6 supplementation with 10 mg/d pyridoxine-HCl for 28-d was given to oral contraceptive (OC) users who initially had vitamin B6 deficiency (PLP < 30 nmol/L). Samples are analyzed before and after supplementation. In addition samples from OC users with low (PLP < 30 nmol/L) , middle (PLP 31-99 nmol/L) and high (PLP > 100 nmol/L) vitamin B6 concentration are compared.

2015-03-13 | ST000293 | MetabolomicsWorkbench

Bacterial vitamin B6 is required for post-embryonic development in C. elegans

Project description:Bacterial vitamin B6 is required for post-embryonic development in C. elegans

| PRJNA1069772 | ENA

A retrospective study on serum vitamin levels and their clinical implications in hospitalized patients with five kinds of common major chronic diseases

Project description:Interventions: Observation group:None Primary outcome(s): Serum vitamin A levels;Serum vitamin B1 levels;Serum vitamin B2 levels;Serum vitamin B6 levels;Serum vitamin B9 levels;Serum vitamin B12 levels;Serum vitamin C levels;Serum vitamin D levels;Serum vitamin E levels Study Design: Cross-sectional

| 85437 | ecrin-mdr-crc

Raoultella ornithinolytica B6 strain:B6

Project description:Raoultella ornithinolytica B6 strain:B6 Genome sequencing

| PRJNA187030 | ENA